Biotechnology
Biotechnology can be divided into 4 main areas:
-
Production of biomass
-
Fermentations: 'life in the absence of oxygen'. Today, the term is taken to mean: 'biological processes that occur in the dark & do not involve respiratory chains with oxygen or nitrate as electron acceptors'.
-
Harnessing of microbial secondary metabolism.
-
The use of genetically manipulated organisms (GMOs).
Biomass Production
-
Source of renewable energy, e.g. Brazilian 'Gasohol'.
-
Production of microbial protein (or 'single cell protein - SCP'):
| Microorganism: |
Company: |
Carbon Source: |
| Candida lipolytica |
B.P. |
C12-C18 aliphatic hydrocarbons from crude petroleum |
| Methylophilus methylotrophus |
I.C.I. |
Methane from natural gas or methanol |
| Fusarium graminarum |
I.C.I. |
Marketed in the UK as "Quorn" ® |
 |
Fermentation:
- Biochemicals:
Amino acids Citric acid Enzymes Vitamins
- Transformations of steriods
- Industrial chemicals
- Foodstuffs:
Baking Dairy products Condiments
Alcohol Production:
|
Brewing Beer:
Industrial biochemicals may be produced in very large fermenters (thousands of litres) running continuously & capable of producing tons of these chemicals per month:

Secondary metabolites
Production of antibiotics, e.g. Penicillium spp. (e.g. P. notatum ) & Streptomycetes:

Genetic Engineering
Some of the products now being produced by this technology include:
- Vaccines.
- A number of human growth hormones, blood clotting agents (factor VIII), insulin & potential anti-cancer agents have been produced in bacteria.
- Insect control - two groups of microorganisms have been used as insecticides:
Bacillus thuringiensis - produces a toxin which kills certain species of caterpillars
Baculoviruses - infect & kill certain species of insect.
$$$ BIOTECHNOLOGY $$$ (US $ billion) |
| Activity: |
1991: |
1992: |
% change: |
| Sales: |
6 |
7 |
+17% |
| Revenue: |
8.3 |
10 |
+20% |
| R&D Expenditure: |
5 |
5.7 |
+14% |
| # Companies: |
1,231 |
1,272 |
+3% |
| # Employees: |
79,000 |
97,000 |
+23% |
| Product: |
Company: |
1991 Sales: |
| Erythropoietin |
Amgen/Genetics Institute |
1,125 |
| Hepatitis B vaccine |
Biogen |
724 |
| Human insulin |
Genentech |
625 |
| Human growth hormone |
Genentech |
575 |
| Alpha-interferon |
Genentech |
565 |
| G-CSF |
Genentech / Biogen / Wellcome |
544 |
| TPA |
Amgen |
230 |
| GM-CSF |
Genentech |
70 |
| Gamma-interferon |
Immunex / Genetics Institute |
25 |
| IL-2 |
Genentech / Biogen |
20 |
| TOTAL: |
Immunex / Chiron |
4,503 |
Source: ASM News 59:550-551 (1993)
- In a time of recession, biotechnology continues to be an expanding sector of the economy of most developed countries & offers future prospects of continued medical & environmental advances in the production of a widening range of compounds.
- The pharmaceutical industry in particular is a prominent source of well-paid jobs for microbiologists!